Search

everythinglearnresearchcommunity

for

Search:↓

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Method can accurately measure five BPH drugs at once.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Plant extracts may help treat hormone-related hair loss.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Beta-blockers and anti-anginal medications have various side effects and interactions that require careful monitoring and individualized treatment.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Dutasteride and finasteride don't raise erectile dysfunction risk.

New treatments for chronic central serous chorioretinopathy show promise in preventing permanent vision loss.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

Modern lifestyles, including poor diet, stress, and long-term use of certain medications, hinder the body's ability to heal from inflammation, leading to chronic diseases.

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Correcting vitamin D and progesterone deficiencies can significantly improve hair loss, acne, and BPH symptoms.

Stauntonia hexaphylla extract can help treat hair loss by blocking certain hormones.

Re-evaluating minoxidil, reducing sodium intake, and addressing arteriolar hypertrophy can improve hypertension management.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.